Perspective Therapeutics (CATX) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Perspective Therapeutics (CATX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Perspective Therapeutics | 361.95 Mn | 361.95 Mn | - | 114.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.09 Mn |
| Mar 31, 2026 | 114.02 Mn |
| Dec 31, 2025 | 74.34 Mn |
| Sep 30, 2025 | 74.34 Mn |
| Jun 30, 2025 | 74.26 Mn |
| Mar 31, 2025 | 74.05 Mn |
| Dec 31, 2024 | 70.67 Mn |
| Sep 30, 2024 | 67.56 Mn |
| Jun 30, 2024 | 67.43 Mn |
| Mar 31, 2024 | 58.69 Mn |
| Dec 31, 2023 | 28.18 Mn |
| Sep 30, 2023 | 28.06 Mn |
| Jun 30, 2023 | 28.05 Mn |
| Mar 31, 2023 | 22.86 Mn |
| Dec 31, 2022 | 14.21 Mn |
| Sep 30, 2022 | 14.21 Mn |
| Jun 30, 2022 | 14.20 Mn |
| Mar 31, 2022 | 14.20 Mn |
| Dec 31, 2021 | 14.20 Mn |
| Sep 30, 2021 | 14.19 Mn |